But a vaccine not too long ago developed by pharmaceutical maker Merck might finally provide a technique to cease Ebola. The vaccine was first tested in late 2015, toward the end of an Ebola outbreak in west Africa, and of the 7,500 individuals who obtained it, not a single one developed the illness. In May 2018, with a new outbreak raging within the Congo, Nationwide Public Radio reported that hundreds of...
